Press release
Diuretic Drugs Market Expected to Reach Record High as Health Concerns Rise
Diuretics, also known as water pills, are a class of drugs that increase urine production and promote the excretion of excess water and salt from the body. They are commonly used to treat conditions such as high blood pressure, heart failure, and edema (swelling caused by excess fluid in the body).๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐ญ: https://www.alliedmarketresearch.com/request-toc-and-sample/8472
๐๐ก๐๐ซ๐ ๐๐ซ๐ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐ญ๐ฒ๐ฉ๐๐ฌ ๐จ๐ ๐๐ข๐ฎ๐ซ๐๐ญ๐ข๐๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Thiazide diuretics: These drugs work by inhibiting the reabsorption of sodium and chloride in the kidneys, which increases the excretion of water and electrolytes. Examples include hydrochlorothiazide and chlorthalidone.
Loop diuretics: These drugs act on the loop of Henle in the kidneys, blocking the reabsorption of sodium, chloride, and water. Examples include furosemide and bumetanide.
Potassium-sparing diuretics: These drugs reduce the excretion of potassium in the urine and can help prevent hypokalemia (low potassium levels). Examples include spironolactone and eplerenone.
Carbonic anhydrase inhibitors: These drugs inhibit the enzyme carbonic anhydrase, which reduces the reabsorption of bicarbonate and increases the excretion of water and electrolytes. Examples include acetazolamide.
๐๐ข๐ฌ๐ข๐ง๐ ๐ฉ๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐ก๐ฒ๐ฉ๐๐ซ๐ญ๐๐ง๐ฌ๐ข๐จ๐ง ๐๐ง๐ ๐ค๐ข๐๐ง๐๐ฒ ๐๐ข๐ฌ๐จ๐ซ๐๐๐ซ๐ฌ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
According to the World health Organization, fatalities caused due to hypertension are estimated 7.5 million worldwide, which accounts for 12.8% of global deaths. Assumptions are made that this would increase to 1.56 billion by 2025. Hypertension is more often seen in elderly population ageing above 60. Increasing prevalence of hypertension is the key factor driving the market growth of diuretic drugs therapy as diuretics are commonly used in the treatment of hypertension.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.alliedmarketresearch.com/purchase-enquiry/8472
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
1. Merck & Co.
2. Meda Manufacturing GmbH
3. Sanofi-aventis U.S.
4. Centaur Pharmaceuticals
5. Validus Pharmaceuticals
6. Pfizer Inc.
7. Glaxosmithkline
8. Roche
9. Paddock Laboratories
10. Perrigo Pharmaceuticals Company.
โ๐๐ข๐ฎ๐ซ๐๐ญ๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ, 2020-2027 ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
1. By Product Type:
a) Loop Diuretics: These drugs act on the loop of Henle in the kidneys, blocking the reabsorption of sodium, chloride, and water. They are used to treat edema caused by congestive heart failure, liver disease, or kidney disease. They are also used to treat hypertension. Examples of loop diuretics include furosemide, bumetanide, and torsemide.
b) Thiazide Diuretics: These drugs work by inhibiting the reabsorption of sodium and chloride in the kidneys, which increases the excretion of water and electrolytes. They are used to treat hypertension, edema, and heart failure. Examples of thiazide diuretics include hydrochlorothiazide, chlorthalidone, and indapamide.
c) Potassium-sparing Diuretics: These drugs reduce the excretion of potassium in the urine and can help prevent hypokalemia (low potassium levels). They are used to treat hypertension and heart failure. Examples of potassium-sparing diuretics include spironolactone, eplerenone, and amiloride.
d) Carbonic Anhydrase Inhibitors: These drugs inhibit the enzyme carbonic anhydrase, which reduces the reabsorption of bicarbonate and increases the excretion of water and electrolytes. They are used to treat glaucoma and altitude sickness. Examples of carbonic anhydrase inhibitors include acetazolamide and dorzolamide.
e) Miscellaneous Diuretics: These are diuretics that do not fall into the above categories. They are used to treat a variety of conditions such as hypertension, heart failure, and edema. Examples of miscellaneous diuretics include osmotic diuretics such as mannitol and glycerol.
2. By Indications:
a) Hypertension: Diuretics are commonly used to treat hypertension (high blood pressure). Thiazide diuretics are usually the first choice for treating hypertension.
b) Glaucoma: Carbonic anhydrase inhibitors are used to treat glaucoma, a condition where there is increased pressure in the eye.
c) Cardiovascular Diseases: Diuretics are used to treat a variety of cardiovascular diseases such as heart failure, edema, and hypertension.
d) Kidney Disorders: Diuretics are used to treat kidney disorders such as nephrotic syndrome, kidney stones, and acute renal failure.
3. By Route of Administration:
a) Oral: Diuretics are commonly administered orally in the form of tablets or capsules.
b) Intravenous: Diuretics can also be given intravenously in hospital settings.
4. By Distribution Channels:
a) Hospital Pharmacies: Diuretics are commonly distributed through hospital pharmacies.
b) Retail Pharmacies: Diuretics can also be obtained through retail pharmacies with a prescription.
๐๐ก๐ ๐๐ข๐ฎ๐ซ๐๐ญ๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ง๐๐ฅ๐ฒ๐ณ๐๐ ๐๐ฒ ๐ซ๐๐ ๐ข๐จ๐ง ๐๐ฌ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ฌ:
North America: The North American market is expected to be a major market for diuretic drugs due to the increasing prevalence of hypertension and heart failure in the region. The market is also driven by the presence of key players in the region, such as Pfizer, Merck, and Bristol-Myers Squibb.
Europe: The European market for diuretic drugs is expected to grow steadily due to the increasing prevalence of chronic kidney diseases and hypertension. The market is also driven by the presence of key players in the region, such as Novartis, Sanofi, and AstraZeneca.
Asia-Pacific: The Asia-Pacific market for diuretic drugs is expected to witness significant growth due to the increasing incidence of hypertension and cardiovascular diseases in the region. The market is also driven by the presence of key players in the region, such as Daiichi Sankyo, Takeda Pharmaceutical, and Lupin.
LAMEA: The LAMEA (Latin America, Middle East, and Africa) market for diuretic drugs is expected to witness moderate growth due to the increasing prevalence of chronic kidney diseases and hypertension in the region. The market is also driven by the presence of key players in the region, such as Teva Pharmaceutical and Mylan.
๐๐ฎ๐ฒ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ข๐ฎ๐ซ๐๐ญ๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/checkout-final/009f7e36e6f036957ae380bb02fbc6ef
๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐?
1. What are the potential side effects of using diuretic drugs?
2. How do diuretic drugs affect electrolyte levels in the body?
3. What is the mechanism of action of loop diuretics?
4. How do thiazide diuretics differ from loop diuretics in terms of their mechanism of action?
5. Which types of diuretic drugs are commonly used to treat glaucoma, and how do they work?
6. What are some key factors driving the growth of the diuretic drugs market?
7. How do potassium-sparing diuretics differ from other types of diuretic drugs?
8. What are the potential drug interactions of diuretic drugs, and how can they be managed?
9. How do diuretic drugs impact fluid balance in the body?
10. What are some of the challenges facing the diuretic drugs market, and how can they be addressed?
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐จ๐ญ๐ก๐๐ซ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐ ๐๐ฒ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Lateral Flow Assays Market https://www.alliedmarketresearch.com/lateral-flow-assay-market
Intravascular Temperature Management Market https://www.alliedmarketresearch.com/intravascular-temperature-management-market
pharmacogenomics market https://www.alliedmarketresearch.com/pharmacogenomics-market
Artificial Intelligence for Drug Discovery and Development Market https://www.alliedmarketresearch.com/artificial-intelligence-for-drug-development-and-discovery-market
Cell Therapy Market https://www.alliedmarketresearch.com/cell-therapy-market
Ophthalmic Viscoelastic Devices (OVD) Market https://www.alliedmarketresearch.com/ovd-market
Mobile Gamma Cameras Market https://www.alliedmarketresearch.com/mobile-gamma-cameras-market
Hybrid Operating Room Market https://www.alliedmarketresearch.com/hybrid-operating-room-market
Digital Diabetes Management Market https://www.alliedmarketresearch.com/digital-diabetes-management-market-A06052
Surgical Lights market https://www.alliedmarketresearch.com/surgical-lights-market-A06076
Pharmaceutical Drug Delivery Market https://www.alliedmarketresearch.com/pharmaceutical-drug-delivery-market-A06102
VR In Healthcare Market https://www.alliedmarketresearch.com/vr-in-healthcare-market-A06193
About Us -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diuretic Drugs Market Expected to Reach Record High as Health Concerns Rise here
News-ID: 2968318 • Views: โฆ
More Releases from Allied Market Reserach

Blockchain Technology Market Size, Share, Growth, Competitive Landscape and Indu โฆ
According to the report, the blockchain technology market was valued at $12.5 Billion in 2023 and is estimated to reach $797.1 Billion by 2032, growing at a CAGR of 57.7% from 2024 to 2032.
Growing demand for decentralized financial solutions and the integration of blockchain technology into a variety of industries are expected to provide ample opportunities for the market growth during the forecast period. However, lack of a skilled workforceโฆ

Bone Void Fillers Market to Surpass $7 Billion by 2031 as Demand for Innovative โฆ
๐๐๐๐จ๐ซ๐๐ข๐ง๐ ๐ญ๐จ ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ฒ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐ญ๐ก๐ ๐๐จ๐ง๐ ๐ฏ๐จ๐ข๐ ๐๐ข๐ฅ๐ฅ๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ $3.2 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2021, ๐๐ง๐ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก $7.3 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ 2031, ๐ ๐ซ๐จ๐ฐ๐ข๐ง๐ ๐๐ญ ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ (๐๐๐๐) ๐จ๐ 8.5% ๐๐ซ๐จ๐ฆ 2022 ๐ญ๐จ 2031. The increasing prevalence of bone disorders and the rise in the geriatric population are some of the key factors driving the growth of this market. Additionally,โฆ

Unraveling the Dynamics of the Cerebrospinal Fluid (CSF) Management Devices Mark โฆ
Cerebrospinal fluid (CSF) is a clear, colorless fluid that surrounds the brain and spinal cord. It plays important roles in protecting and nourishing the central nervous system (CNS). CSF is produced by the choroid plexus, a specialized tissue in the brain, and it circulates throughout the CNS, bathing the brain and spinal cord.
However, in some cases, there may be abnormalities in the production, circulation, or absorption of CSF, leading toโฆ

Growing Demand for Sugar-Based Excipients in Pharmaceutical Formulations Drives โฆ
Sugar-based excipients have gained widespread acceptance in the pharmaceutical industry as ingredients in tablet formulations. They are commonly used to mask the bitter taste of active pharmaceutical ingredients (APIs), making the tablets more palatable for patients. With the growing preference for direct compression as a method of tablet manufacture, there has been an increased demand for compressible sugar-based excipients.
Direct compression is a popular tablet manufacturing method because it offers advantagesโฆ
More Releases for Diuretic
Anti-Diuretic Drugs Market: 2024 Industry Size, Shares, Segment & Forecast up to โฆ
The global anti-diuretic drugs market reached a valuation of USD 494.13 million in 2023 and is expected to experience a robust growth rate, registering a compound annual growth rate (CAGR) of 13.4% throughout the forecast period. This steady market growth is attributed to a variety of factors including the increasing geriatric population affected by diabetes insipidus, ongoing clinical trials, and approvals of new drugs by the U.S. Food and Drugโฆ
Diuretic Drugs Market Size, Scope, Insight, Demand & Global Industry analysis of โฆ
Market Definition:
Diuretic, also known as water or fluid pills, are therapeutics that promote urine. Diuretics therapies are used to treat cardiovascular disease and water retention problems by decreasing the amount of salt in the body. It is also given in the treatment of kidney failure and cirrhosis of the liver. The global diuretic drugs market is expected to witness significant growth during the forecast period, driven by the increase inโฆ
Diuretic Drugs Market Set to Reach USD 157.2 Mn by 2031, with 5.5% CAGR
The latest research study released by Transparency Market Research on "Diuretic Drugs Market Forecast to 2023-2031 โณ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Diuretic Drugs industry, as well asโฆ
Diuretic Drugs Market to Expand at a CAGR of 5.5% during 2023-2031
The global Diuretic Drugs Market size was valued at US$ 98.8 Mn in 2022 and is estimated to reach US$ 157.2 Mn by 2031. The market is likely to expand at a CAGR of 5.5% between 2023 and 2031. The rise in chronic illnesses, such as stroke, heart disease, hypertension, diabetes, and cancer, is expected to raise the market value of diuretic drugs. Additionally, increasing demand for diuretic drugs amongโฆ
Diuretic Drugs Market to Experience Exponential Growth during forecast period
According to a new report published by Allied Market Research, titled, " Diuretic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Diuretic Drugs is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.
Click Here To Access Free Sample Report https://www.alliedmarketresearch.com/request-sample/8472
Some of the keyโฆ
Diuretic Drugs Market Augmented Expansion to be Registered by 2018 to 2028
Diuretic Drugs are also known as 'water pills'. Diuretic drugs get rid of extra water in the body and lower blood pressure. Diuretic drugs are a class of drugs that increase the flow of urine in the body. They do so by reducing the sodium and chloride concentration in the body by removing it through the urine. This leads the body to draw excess water from the body. The sodiumโฆ